These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21149913)

  • 1. Antiviral therapy for hepatitis B in special populations.
    Zhang FK; Liu DG; Jia JD
    Antivir Ther; 2010; 15(8):1067-75. PubMed ID: 21149913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of special populations with chronic hepatitis B infection.
    Rapti IN; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):323-39. PubMed ID: 21651351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special populations with hepatitis B virus infection.
    Peters MG
    Hepatology; 2009 May; 49(5 Suppl):S146-55. PubMed ID: 19399810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW; Chen YG
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Nucleoside analogues for the treatment of chronic hepatitis B.
    Younger HM; Bathgate AJ; Hayes PC
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1211-30. PubMed ID: 15606384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy.
    Terrault NA; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():18-24. PubMed ID: 17701846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine for patients with chronic hepatitis B and advanced liver disease.
    Liaw YF; Sung JJ; Chow WC; Farrell G; Lee CZ; Yuen H; Tanwandee T; Tao QM; Shue K; Keene ON; Dixon JS; Gray DF; Sabbat J;
    N Engl J Med; 2004 Oct; 351(15):1521-31. PubMed ID: 15470215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
    Wang L; Yan J; Zhang ZH; Wang JB; Du YZ; Li XY; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy for chronic hepatitis B.
    Jafri SM; Lok AS
    Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
    Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatitis B carrier state.
    Murray BJ
    Am Fam Physician; 1986 Apr; 33(4):127-33. PubMed ID: 2938461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of telbivudine in pregnant chronic hepatitis B patients].
    Zhou YJ; Zheng JL; Pan HJ; Jiang S
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):861-2. PubMed ID: 22553840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)].
    Buti M; García-Samaniego J; Prieto M; Rodríguez M; Sánchez-Tapias JM; Suárez E; Esteban R
    Gastroenterol Hepatol; 2012; 35(7):512-28. PubMed ID: 22749508
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B in pregnancy.
    Whittaker G; Herrera JL
    South Med J; 2014 Mar; 107(3):195-200. PubMed ID: 24937341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.